Hepatocellular carcinoma (HCC) – a role of surgical resection and liver transplantation for the treatment of HCC

Journal Title: Postępy Nauk Medycznych - Year 2010, Vol 23, Issue 1

Abstract

Hepatocellular carcinoma (HCC) is one of the common malignant tumors worldwide and is the fifth leading cause of death on a worldwide basis. The major risk factors for development of HCC are now well defined: cirrhosis, regardless of etiology, chronic viral hepatitis B,C and D, toxins and drugs(e.g. alcohol, aflatoxins, anabolic steroids) and metabolic liver diseases (e.g., hereditary hemochromatosis, alfa1-antitrypsin deficiency). Clinical presentation is not typical and different, depending on stage at discovery, and hepatic dysfunction, and the geographic location of the patient. Routine imaging with USG, CT scan and MRI is the diagnostic procedure and follow abnormal laboratory tests. Many centers employed the screening protocol(AFP test, ultrasound) to detect and to determine the stage cancer early. This strategy allow selection of optimal treatment procedure and reduce mortality. The optimal treatment for HCC is surgical resection with the curative intent. Percutaneous ethanol injection has been widely performed as an alternative to surgery in patients with small HCCs. Radiofrequency ablation produces thermal destruction with an electric current that passes to the tumor via electrode tip, resulting in heat generation and coagulative necrosis. Transcatheter arterial chemoembolisation is one of the popular and effective treatments for patients with unresectable HCC. Targeted therapy ( monoclonal antybodies, receptor kinase inhibitors) may inhibits tumor progression. Liver transplantation is an therapeutic option in patients with HCC. The treatment of HCC by liver transplantation has evolved during decades in term to determine the best criteria of patients selection and optimal treatment protocols pre- and posttransplantation. Preoperative diagnostic should be as extensive as needed to accurately assess the morphological and biological characteristics of tumor – criteria for transplant candidacy. Adjuvant chemotherapy is a part of treatment protocols in many centers. It is evident from the published results that liver transplantation is the best chance for cure in patients with early HCC. The important factor in reducing of metastatic disease occurrence after ltx is optimal immunosuppressive regimen. The further efforts should be made to improve the results of liver transplantation.

Authors and Affiliations

Marek Krawczyk, Urszula Ołdakowska-Jedynak

Keywords

Related Articles

Wpływ atorwastatyny i perindoprilu na cykl włosowy na modelu zwierzęcym – ryzyko łysienia polekowego u pacjentów kardiologicznych

<b>Wstęp. </b>Ważne zagadnienie z punktu widzenia klinicystów i pacjentów stanowią niepożądane działania polekowe. Obejmują one wiele układów i narządów oraz implikują dalsze postępowanie tera...

Terapia behawioralna bólu u dzieci i młodzieży

Celem artykułu jest prezentacja behawioralnych technik terapii bólu wykorzystywanych w praktyce klinicznej u dzieci i młodzieży oraz przegląd wyników badań nad ich skutecznością. Podsumowano wyniki badań nad epidemiologi...

Evaluation of the efficacy of intravenous corticotherapy in preventing exacerbation of thyroid orbitopathy in patients with Graves’ disease treated with radioactive iodine due to hyperthyroidism

<b>Introduction.</b> Radioiodine treatment of thyrotoxicosis in Graves’ disease patients may lead to orbitopathy progression. Oral glucocorticoid therapy is a standard method in...

New methods of treatment of cataract

The progressive aging of the population, while growth expectations for the quality of life of patients is the reason for growing interest in the development of new methods of treatment of presbyopy. Surgical treatment of...

Thromboembolic complications (TEC) in patients with acute leukemias and lymphomas – single center experience

<b>Introduction.</b> Thromboembolic complications (TEC) are common abnormalities in cancer patients and they refere expecially to solid tumours. The pathogenesis of thromboembolic disease in n...

Download PDF file
  • EP ID EP53737
  • DOI -
  • Views 236
  • Downloads 0

How To Cite

Marek Krawczyk, Urszula Ołdakowska-Jedynak (2010). Hepatocellular carcinoma (HCC) – a role of surgical resection and liver transplantation for the treatment of HCC. Postępy Nauk Medycznych, 23(1), -. https://www.europub.co.uk/articles/-A-53737